I do not understand why there are any sceptics. If you can induce t cell production without any side effect in humans in an efficient and inexpensive manner, your 90% there. Is it not true that Many t-cell therapies work?
I've seen it over and over again. Stock is downgraded by a number of firms.
Then after a month or two extraordinary news comes out and the sp doubles.
I get the feeling this might happen with INO.
Am I correct in viewing the ebola trial as a proving field for all INO technologies?